37 related articles for article (PubMed ID: 38532545)
21. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
22. Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis.
Shi LF; Wu Y; Li CY
Menopause; 2016 Apr; 23(4):417-24. PubMed ID: 26506499
[TBL] [Abstract][Full Text] [Related]
23. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
24. Update on Menopausal Hormone Therapy for Fracture Prevention.
Stepan JJ; Hruskova H; Kverka M
Curr Osteoporos Rep; 2019 Dec; 17(6):465-473. PubMed ID: 31741221
[TBL] [Abstract][Full Text] [Related]
25. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
26. Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.
Masood DE; Roach EC; Beauregard KG; Khalil RA
Curr Drug Metab; 2010 Oct; 11(8):693-714. PubMed ID: 21189141
[TBL] [Abstract][Full Text] [Related]
27. Prediagnostic use of menopausal hormone therapy and long-term survival of localized epithelial ovarian cancer: The Extreme study.
Duus AH; Hannibal CG; Baandrup L; Zheng G; Galanakis M; Maltesen T; Hertzum-Larsen R; Mørch LS; Kjær SK
Int J Cancer; 2024 Jul; 155(1):19-26. PubMed ID: 38532545
[TBL] [Abstract][Full Text] [Related]
28. Menopausal hormone therapy and women's health: An umbrella review.
Zhang GQ; Chen JL; Luo Y; Mathur MB; Anagnostis P; Nurmatov U; Talibov M; Zhang J; Hawrylowicz CM; Lumsden MA; Critchley H; Sheikh A; Lundbäck B; Lässer C; Kankaanranta H; Lee SH; Nwaru BI
PLoS Med; 2021 Aug; 18(8):e1003731. PubMed ID: 34339416
[TBL] [Abstract][Full Text] [Related]
29. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin.
Pearce CL; Chung K; Pike MC; Wu AH
Cancer; 2009 Feb; 115(3):531-9. PubMed ID: 19127543
[TBL] [Abstract][Full Text] [Related]
30. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract][Full Text] [Related]
31. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
32. Changing concepts: Menopausal hormone therapy and breast cancer.
Chlebowski RT; Anderson GL
J Natl Cancer Inst; 2012 Apr; 104(7):517-27. PubMed ID: 22427684
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
